secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001193125-23-224944
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirum amends severance plan; expands CEO/NEO change-in-control benefits
-----------------------------------------------------------------------

- CEO Peetz: 12mo base salary + 12mo equity vesting (non-CIC); 24mo salary + 200% bonus + full vesting (CIC).
- NEOs Longpre, Radovich, Vig: 9mo salary + 12mo vesting (non-CIC); 18mo salary + 150% bonus + full vesting (CIC).
- Plan amendment removes automatic sunset provision; administrative changes made.
- New participation agreements with each NEO reflect modified benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/0001193125-23-224944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/d549647d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-224944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer